| Saumya Shah, MD | |
|
27 Sycamore St Ste 100, Glastonbury, CT 06033-7208 | |
| (860) 659-0581 | |
| (860) 657-1806 |
| Full Name | Saumya Shah |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 27 Sycamore St Ste 100, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770046369 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 70846 (Connecticut) | Primary |
| Entity Name | Prime Healthcare, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184819302 PECOS PAC ID: 6709787930 Enrollment ID: O20040121000411 |
News Archive
Kaiser Health News staff writer Jay Hancock, working in collaboration with Politico, reports: "If quiet negotiations between policymakers and industry bear fruit, Maryland could join the short list of states attempting to go far beyond the Affordable Care Act in improving health and limiting spending."
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.
The Beryl Companies, the nation's leading provider of outsourced call center services to healthcare organizations, has achieved a growth rate of 41 percent in the last three years, earning it a place in the prestigious Inc. 5000 list of the fastest-growing private companies in the country for the third straight year.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saumya Shah, MD 30 Jordan Ln, Wethersfield, CT 06109-1278 Ph: (860) 263-0253 | Saumya Shah, MD 27 Sycamore St Ste 100, Glastonbury, CT 06033-7208 Ph: (860) 659-0581 |
News Archive
Kaiser Health News staff writer Jay Hancock, working in collaboration with Politico, reports: "If quiet negotiations between policymakers and industry bear fruit, Maryland could join the short list of states attempting to go far beyond the Affordable Care Act in improving health and limiting spending."
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.
The Beryl Companies, the nation's leading provider of outsourced call center services to healthcare organizations, has achieved a growth rate of 41 percent in the last three years, earning it a place in the prestigious Inc. 5000 list of the fastest-growing private companies in the country for the third straight year.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.
How Medicare's Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment - This study examines the impact that Medicare payment cuts for chemotherapy drugs had on treatment for Medicare beneficiaries with newly diagnosed lung cancer, before and after implementation of the June 2005 new payment system, focusing on five chemotherapy drugs "in common use singly or jointly for lung cancer..."
› Verified 7 days ago
Dr. Ernest Luke Squatrito, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 New London Tpke, Suite 103, Glastonbury, CT 06033 Phone: 860-659-5999 Fax: 860-659-5999 | |
Samantha Anthony, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 119 Hebron Ave Unit B, Glastonbury, CT 06033 Phone: 860-996-8117 | |
Arjun Banerjee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Western Boulevard, Building B, Glastonbury, CT 06033 Phone: 860-633-1008 | |
Christabel Ansah, APRN FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 2639 Main St, Glastonbury, CT 06033 Phone: 860-659-1329 | |
Dr. Steven John Rigatti, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 157 Uconn Ave, Glastonbury, CT 06033 Phone: 860-519-6236 | |
Dr. Stephen N Grimaldi, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 Hebron Ave, Suite 101, Glastonbury, CT 06033 Phone: 860-657-4080 Fax: 860-659-3110 |